Avalo Therapeutics, Inc. · NASDAQ:AVTX

Ra Capital Management, L.P. reported a 9.90% stake in Avalo Therapeutics, Inc. (Schedule 13G/A)

Event Mar 31, 2025 · Filed May 15, 2025

Ra Capital Management, L.P. reported a 9.90% stake in Avalo Therapeutics, Inc., 1,094,407 shares, as a passive investor on Mar 31, 2025. Filed May 15, 2025 (Schedule 13G/A).

Stake
9.90%
Shares
1,094,407
Intent
Passive
What changed
Stake changed
Filed together
4 holders

The filing in full

HolderStakeShares
RA Capital Management, L.P.9.90%1,094,407
Peter Kolchinsky9.90%1,094,407
Rajeev Shah9.90%1,094,407
RA Capital Healthcare Fund, L.P.9.90%1,094,407

Source

View original at SEC

Related